Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 2
1975 1
1976 2
1977 1
1978 2
1979 3
1980 1
1982 3
1983 1
1984 1
1985 1
1986 2
1988 5
1989 1
1990 2
1993 1
1994 1
1995 1
1997 3
1998 2
1999 3
2000 1
2001 1
2004 3
2005 1
2006 2
2008 3
2009 1
2010 2
2011 1
2012 3
2013 2
2014 6
2015 3
2016 5
2017 5
2018 7
2019 5
2020 9
2021 9
2022 7
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
Ferrara R, Mezquita L, Texier M, Lahmar J, Audigier-Valette C, Tessonnier L, Mazieres J, Zalcman G, Brosseau S, Le Moulec S, Leroy L, Duchemann B, Lefebvre C, Veillon R, Westeel V, Koscielny S, Champiat S, Ferté C, Planchard D, Remon J, Boucher ME, Gazzah A, Adam J, Bria E, Tortora G, Soria JC, Besse B, Caramella C. Ferrara R, et al. Among authors: leroy l. JAMA Oncol. 2018 Nov 1;4(11):1543-1552. doi: 10.1001/jamaoncol.2018.3676. JAMA Oncol. 2018. PMID: 30193240 Free PMC article.
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.
Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zerón-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B. Mezquita L, et al. Among authors: leroy l. JAMA Oncol. 2018 Mar 1;4(3):351-357. doi: 10.1001/jamaoncol.2017.4771. JAMA Oncol. 2018. PMID: 29327044 Free PMC article.
Optical fiber biosensors toward in vivo detection.
Bratash O, Buhot A, Leroy L, Engel E. Bratash O, et al. Among authors: leroy l. Biosens Bioelectron. 2024 May 1;251:116088. doi: 10.1016/j.bios.2024.116088. Epub 2024 Feb 1. Biosens Bioelectron. 2024. PMID: 38335876 Review.
Polarization Induced Electro-Functionalization of Pore Walls: A Contactless Technology.
Bouchet-Spinelli A, Descamps E, Liu J, Ismail A, Pham P, Chatelain F, Leïchlé T, Leroy L, Marche PN, Raillon C, Roget A, Roupioz Y, Sojic N, Buhot A, Haguet V, Livache T, Mailley P. Bouchet-Spinelli A, et al. Among authors: leroy l. Biosensors (Basel). 2019 Oct 11;9(4):121. doi: 10.3390/bios9040121. Biosensors (Basel). 2019. PMID: 31614545 Free PMC article. Review.
Antitumor Effects of PRMT5 Inhibition in Sarcomas.
Verbeke S, Bourdon A, Guegan JP, Leroy L, Chaire V, Richard E, Bessede A, Italiano A. Verbeke S, et al. Among authors: leroy l. Cancer Res Commun. 2023 Nov 2;3(11):2211-2220. doi: 10.1158/2767-9764.CRC-23-0239. Cancer Res Commun. 2023. PMID: 37861293 Free PMC article.
Camouflage therapy.
LeRoy L. LeRoy L. Dermatol Nurs. 2000 Dec;12(6):415-6, 442. Dermatol Nurs. 2000. PMID: 11912830
Non-equilibrium dynamics of spin-lattice coupling.
Ueda H, Mankowsky R, Paris E, Sander M, Deng Y, Liu B, Leroy L, Nag A, Skoropata E, Wang C, Ukleev V, Perren GS, Dössegger J, Gurung S, Svetina C, Abreu E, Savoini M, Kimura T, Patthey L, Razzoli E, Lemke HT, Johnson SL, Staub U. Ueda H, et al. Among authors: leroy l. Nat Commun. 2023 Nov 27;14(1):7778. doi: 10.1038/s41467-023-43581-9. Nat Commun. 2023. PMID: 38012165 Free PMC article.
Making Healthcare Safer III: A Critical Analysis of Existing and Emerging Patient Safety Practices [Internet].
Hall KK, Shoemaker-Hunt S, Hoffman L, Richard S, Gall E, Schoyer E, Costar D, Gale B, Schiff G, Miller K, Earl T, Katapodis N, Sheedy C, Wyant B, Bacon O, Hassol A, Schneiderman S, Woo M, LeRoy L, Fitall E, Long A, Holmes A, Riggs J, Lim A. Hall KK, et al. Among authors: leroy l. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Mar. Report No.: 20-0029-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Mar. Report No.: 20-0029-EF. PMID: 32255576 Free Books & Documents. Review.
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity.
Labrousse G, Vande Perre P, Parra G, Jaffrelot M, Leroy L, Chibon F, Escudie F, Selves J, Hoffmann JS, Guimbaud R, Lutzmann M. Labrousse G, et al. Among authors: leroy l. NAR Cancer. 2023 Mar 11;5(2):zcad011. doi: 10.1093/narcan/zcad011. eCollection 2023 Jun. NAR Cancer. 2023. PMID: 36915289 Free PMC article.
126 results